India Coronary Stents Market

Coronary stents (CS) are expandable tubular metallic devices, which are introduced into the coronary arteries that shows stenosis due to an underlying atherosclerosis disease. This revascularization procedure is termed as a percutaneous coronary intervention (PCI) or coronary angioplasty with stent placement.

There are main types of stents:

• Bare metal stents (BMS)
• Drug eluting stents (DES)
• Bioresorbable scaffold system (BRS)
• Drug- Eluting balloons (DEB).

DES consists of three components: a metallic stent platform, an active pharmacological drug agent, and a carrier vehicle. Stainless steel or cobalt-chromium is the most common metal and gives long-term mechanical stability to counteract vascular recoil. The drug release is carried out by diffusion through pores in the polymeric coating. While DEB has only antiproliferative drug coating without an underlying metallic structure of the stent, BRS is also devoid of metallic structure and is entirely resorbed in a few months after serving their purpose. Other stents such as bifurcation stents and covered stents are designed for special circumstances such as lesion over vascular bifurcation or coronary artery perforation, respectively.

Market Dynamics

The demand for coronary stents is anticipated to be driven by an ageing population and an increase in the prevalence of risk factors such as cardiovascular diseases (CVDs), complicated lesions, diabetes, obesity, and others. Apart from these governments initiative to reduce the prices of coronary stent by adding them in the list of essential medicines have promoted to shift the customers from the by-pass surgeries to the PCI procedure. For instance, according to report shared on January 13, 2020, the total stents used in India (Indian as well as imported) were 4,50,000 before price cap while they increased in 6,00,000 after the price cap in India.

Key features of the study:

• This report provides an in-depth analysis of the India coronary stent market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the India coronary stent market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott Laboratories, Medtronic, Inc, Biosensors Inc, Terumo Corporation, Boston Scientific Inc.,Becton, Dickinson and Company, Cook medicals, B Braun Melsungen AG, SLTL Medical, Endocare, Cardiac Care Products, Invent Bio-med Private Limited, Nano therapeutics pvt ltd, MIV therapeutics.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• India coronary stent market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the India coronary stent market

Detailed Segmentation:

• India Coronary Stents Market , By Product Type:
  • Drug eluting stents
  • Bare metal stents
  • Bioresorbable vascular scaffold
• India coronary stent market, By Material:
  • Cobalt Chromium
  • Stainless steel
  • Platinum Chromium
  • Nickel Titanium
  • Polymer
• India coronary stent market, By End user:
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization laboratories
• Company Profiles
  • Abbott Laboratories*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Medtronic, Inc.
  • Biosensors, Inc.
  • Terumo corporation
  • Boston Scientific Inc.
  • Becton, Dickinson and Company
  • Cook Medicals
  • B Braun Melsungen AG
  • SLTL Medical
  • Endocare
  • Cardiac Care Products
  • Invent Bio-med Private Limited
  • Nano therapeutics pvt ltd.
  • MIV therapeutics

“*” marked represents similar segmentation in other categories in the respective section